Pfizer (PFE) EBT (2009 - 2026)
Pfizer (PFE) reported EBT of $3.2 billion for Q1 2026, up 13.82% year-over-year from $2.8 billion in Q1 2025, and up 293.06% on a QoQ basis from -$1.6 billion in Q4 2025.
Pfizer (PFE) has 18 years of EBT data on file, last reported at $3.2 billion in Q1 2026.
- Quarterly EBT rose 13.82% year-over-year to $3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 billion (down 26.92% YoY) and the FY2025 annual result came in at $7.5 billion, down 6.27% from the prior year.
- EBT rose to $3.2 billion in Q1 2026 per PFE's latest filing, from -$1.6 billion in the prior quarter.
- Across five years, EBT topped out at $11.4 billion in Q3 2022 and bottomed at -$4.1 billion in Q4 2023.
- The 5-year median for EBT is $3.2 billion (2026), against an average of $3.3 billion.
- The widest annual swing landed in 2023, when EBT sank 137.24%; it then jumped 3055.34% in 2025.
- Tracing PFE's EBT over 5 years: stood at $9.0 billion in 2022, then slumped by 145.87% to -$4.1 billion in 2023, then surged by 214.19% to $4.7 billion in 2024, then slumped by 134.83% to -$1.6 billion in 2025, then jumped by 293.06% to $3.2 billion in 2026.
- Per Business Quant, the three latest PFE EBT figures stand at $3.2 billion (Q1 2026), -$1.6 billion (Q4 2025), and $3.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 8.85 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 5.99 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 1.04 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -3.50 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.08 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.58 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 3.17 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 3.24 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.17 Bn |
| Dec 31, 2025 | -1.64 Bn |
| Sep 28, 2025 | 3.33 Bn |
| Jun 29, 2025 | 3.04 Bn |
| Mar 30, 2025 | 2.79 Bn |
| Sep 29, 2024 | 4.72 Bn |
| Jun 30, 2024 | -103.00 Mn |
| Mar 31, 2024 | 3.42 Bn |
| Dec 31, 2023 | -4.13 Bn |
| Oct 1, 2023 | -3.35 Bn |
| Jul 2, 2023 | 2.27 Bn |
| Apr 2, 2023 | 6.27 Bn |
| Oct 2, 2022 | 9.00 Bn |
| Jul 3, 2022 | 11.45 Bn |
| Apr 3, 2022 | 9.05 Bn |
| Oct 3, 2021 | 7.84 Bn |
| Jul 4, 2021 | 6.95 Bn |
| Apr 4, 2021 | 5.69 Bn |
| Sep 27, 2020 | 570.00 Mn |
| Jun 28, 2020 | 3.03 Bn |
| Mar 29, 2020 | 2.84 Bn |
| Dec 31, 2019 | -7.87 Bn |
| Sep 29, 2019 | 10.73 Bn |
| Jun 30, 2019 | 4.14 Bn |
| Mar 31, 2019 | 4.32 Bn |
| Dec 31, 2018 | -9.24 Bn |
| Sep 30, 2018 | 4.18 Bn |
| Jul 1, 2018 | 4.53 Bn |
| Apr 1, 2018 | 4.13 Bn |
| Dec 31, 2017 | 954.00 Mn |
| Oct 1, 2017 | 3.59 Bn |
| Jul 2, 2017 | 3.82 Bn |
| Apr 2, 2017 | 3.95 Bn |
| Dec 31, 2016 | 776.00 Mn |
| Oct 2, 2016 | 1.60 Bn |
| Jul 3, 2016 | 2.41 Bn |
| Apr 3, 2016 | 3.56 Bn |
| Dec 31, 2015 | -354.00 Mn |
| Sep 27, 2015 | 2.70 Bn |
| Jun 28, 2015 | 3.54 Bn |
| Mar 29, 2015 | 3.08 Bn |
| Dec 31, 2014 | 1.80 Bn |
| Sep 28, 2014 | 3.59 Bn |
| Jun 29, 2014 | 4.00 Bn |
| Mar 30, 2014 | 2.85 Bn |
| Dec 31, 2013 | 3.06 Bn |
| Sep 29, 2013 | 3.57 Bn |
| Jun 30, 2013 | 5.36 Bn |
| Mar 31, 2013 | 3.73 Bn |
| Dec 31, 2012 | 2.08 Bn |
| Sep 30, 2012 | 2.81 Bn |
| Jul 1, 2012 | 4.18 Bn |
| Apr 1, 2012 | 2.44 Bn |
| Dec 31, 2011 | 1.33 Bn |
| Oct 2, 2011 | 3.54 Bn |
| Jul 3, 2011 | 3.60 Bn |
| Apr 3, 2011 | 3.12 Bn |
| Dec 31, 2010 | 982.00 Mn |
| Oct 3, 2010 | 1.41 Bn |
| Jul 4, 2010 | 3.93 Bn |
| Apr 4, 2010 | 3.15 Bn |
| Dec 31, 2009 | -149.00 Mn |
| Sep 27, 2009 | 3.97 Bn |
| Jun 28, 2009 | 3.05 Bn |
| Mar 29, 2009 | 3.80 Bn |